Literature DB >> 1580237

Socioeconomic factors and race in breast cancer recurrence and survival.

N H Gordon1, J P Crowe, D J Brumberg, N A Berger.   

Abstract

The relation of breast cancer recurrence and overall survival to age, level of estrogen receptors, number of positive lymph nodes, obesity, race, socioeconomic status, and tumor size at the time of diagnosis was considered for 1,392 breast cancer patients (253 black, 1,132 white, and 7 of other races) entered into two multi-institutional prospective clinical trials. Baseline for the first trial was 1974-1979, and that for the second was 1980-1985; follow-up for this report ended in August 1990. Univariately, all factors except age and obesity were significantly related to disease-free survival, and all except age were significantly related to overall survival. A multivariate analysis using Cox's proportional hazards model indicated that a greater number of positive lymph nodes, a larger tumor diameter, lower socioeconomic status, and negative estrogen receptors were significantly related to shorter disease-free survival. After adjustment for socioeconomic status, race ceased to be a significant indicator of either disease-free survival or overall survival. Patients of either race who are of a lower socioeconomic status are more likely to have a recurrence and to die of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580237     DOI: 10.1093/oxfordjournals.aje.a116340

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

Review 1.  New understanding of poverty and health.

Authors:  M McGregor
Journal:  Can Fam Physician       Date:  1999-12       Impact factor: 3.275

2.  Geographic socioeconomic status, race, and advanced-stage breast cancer in New York City.

Authors:  Sharon Stein Merkin; Lori Stevenson; Neil Powe
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

Review 3.  Nutrition and survival after the diagnosis of breast cancer: a review of the evidence.

Authors:  Cheryl L Rock; Wendy Demark-Wahnefried
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

4.  Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975-2001.

Authors:  Kevin M Gorey; Isaac N Luginaah; Kendra L Schwartz; Karen Y Fung; Madhan Balagurusamy; Emma Bartfay; Frances C Wright; Uzoamaka Anucha; Renee R Parsons
Journal:  Breast Cancer Res Treat       Date:  2008-03-11       Impact factor: 4.872

5.  Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records.

Authors:  U Macleod; S Ross; C Twelves; W D George; C Gillis; G C Watt
Journal:  BMJ       Date:  2000-05-27

6.  Harvard report on cancer prevention. Causes of human cancer. Socioeconomic status.

Authors: 
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

7.  Unemployment and the likelihood of detecting early-stage breast cancer.

Authors:  R A Catalano; W A Satariano
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

8.  Participation in clinical trials: is it state-of-the-art treatment for African Americans and other people of color?

Authors:  C R Thomas; H A Pinto; M Roach; C B Vaughn
Journal:  J Natl Med Assoc       Date:  1994-03       Impact factor: 1.798

9.  All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997.

Authors:  Kyle Steenland; Sherry Hu; James Walker
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

10.  Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada.

Authors:  Alireza Sadjadi; T Gregory Hislop; Chris Bajdik; Morteza Bashash; Anahita Ghorbani; Mehdi Nouraie; Masoud Babaei; Reza Malekzadeh; Parvin Yavari
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.